tiprankstipranks
Trending News
More News >
Phathom Pharmaceuticals (PHAT)
NASDAQ:PHAT
US Market

Compare Phathom Pharmaceuticals (PHAT) vs. Competitors

Compare
587 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Compare
Top Analysts' Price Target
Smart Score
Follow
Phathom Pharmaceuticals
$12.41
$1.04B
-3.25
95.74%
6 Buy
1 Hold
0 Sell
Strong Buy
Geron
$1.47
$938.38M
-12.15
-51.66%
3 Buy
1 Hold
0 Sell
Strong Buy
Arbutus Biopharma
$3.67
$746.22M
-16.55
2.23%
1 Buy
0 Hold
0 Sell
Moderate Buy
Urogen Pharma
$20.71
$969.41M
-5.93
76.29%
5 Buy
0 Hold
0 Sell
Strong Buy
Taysha Gene Therapies
$4.41
$1.24B
-12.44
160.95%
8 Buy
0 Hold
0 Sell
Strong Buy
Zenas BioPharma, Inc.
$21.01
$1.11B
-4.64
165.28%
4 Buy
1 Hold
0 Sell
Strong Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
PHAT
Phathom Pharmaceuticals
12.41
6.51
110.34%
GERN
Geron
1.46
-1.47
-50.17%
ABUS
Arbutus Biopharma
3.67
0.26
7.62%
URGN
Urogen Pharma
20.52
9.57
87.40%
TSHA
Taysha Gene Therapies
4.41
2.75
165.66%
ZBIO
Zenas BioPharma, Inc.
21.01
13.16
167.64%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts